Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

iLet Dosing Decision Software Postmarket Surveillance Plan (PS240001): The iLet Experience Study

NCT06891898 is registered in ClinicalTrials.gov with Beta Bionics, Inc. as lead sponsor.

NCT NCT06891898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06891898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
iLet Dosing Decision Software Postmarket Surveillance Plan (PS240001): The iLet Experience Study
Lead sponsor
Beta Bionics, Inc.
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2024
Completion date
June 30, 2027
Enrollment
1,875 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes